We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+9.09%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$18.6B
AUM Growth
+$370M
(+2%)
Cap. Flow
-$1.05B
Cap. Flow
% of AUM
-5.64%
Top 10 Holdings %
Top 10 Hldgs %
19.87%
Holding
1,286
New
95
Increased
394
Reduced
580
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$42.1M |
| 2 |
Amazon
AMZN
|
+$37.3M |
| 3 |
Agilent Technologies
A
|
+$34.9M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$34.7M |
| 5 |
Netflix
NFLX
|
+$33.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$132M |
| 2 |
Cencora
COR
|
+$65.6M |
| 3 |
Biogen
BIIB
|
+$53.3M |
| 4 |
Applied Materials
AMAT
|
+$44.9M |
| 5 |
Dollar General
DG
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.39% |
| 2 | Healthcare | 13.06% |
| 3 | Financials | 11.34% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Moog Inc Class A
MOG.A
$13.1B
| $266K | ﹤0.01% |
3,211
-516
| -14% | -$41.3K |
|
1002
Phreesia
PHR
$671M
| $265K | ﹤0.01% |
5,115
| – | – |
|
1003
Franco-Nevada
FNV
$40.6B
| $263K | ﹤0.01% |
2,110
| – | – |
|
1004
Public Storage
PSA
$61.7B
| $263K | ﹤0.01% |
1,072
-2,091
| -66% | -$487K |
|
1005
Columbia Sportswear
COLM
$3.3B
| $262K | ﹤0.01% |
2,486
-540
| -18% | -$53.4K |
|
|
ZEN
1006
DELISTED
ZENDESK INC
ZEN
| $262K | ﹤0.01% |
+1,980
| New | +$284K |
|
|
KYNB
1007
Kyntra Bio
KYNB
$28.2M
| $261K | ﹤0.01% |
302
+4
| +1% | +$4.26K |
|
1008
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.83B
| $260K | ﹤0.01% |
7,156
| – | – |
|
1009
Boston Scientific
BSX
$68.5B
| $259K | ﹤0.01% |
6,720
+874
| +15% | +$33.1K |
|
1010
Pembina Pipeline
PBA
$29B
| $258K | ﹤0.01% |
8,975
-825
| -8% | -$22.9K |
|
1011
Ingersoll Rand
IR
$33.9B
| $257K | ﹤0.01% |
5,258
-286
| -5% | -$13.2K |
|
1012
Infosys
INFY
$50B
| $256K | ﹤0.01% |
13,724
-49
| -0.4% | -$887 |
|
|
CS
1013
DELISTED
Credit Suisse Group
CS
| $255K | ﹤0.01% |
24,113
-55,892
| -70% | -$757K |
|
1014
Brookfield Infrastructure Partners
BIP
$19.3B
| $254K | ﹤0.01% |
7,179
-2,250
| -24% | -$78.4K |
|
1015
Takeda Pharmaceutical
TAK
$56B
| $253K | ﹤0.01% |
+13,913
| New | +$250K |
|
1016
Cleveland-Cliffs
CLF
$6.84B
| $252K | ﹤0.01% |
12,568
-4,788
| -28% | -$77.9K |
|
1017
Hasbro
HAS
$13.6B
| $252K | ﹤0.01% |
2,637
-1,239
| -32% | -$118K |
|
1018
Blackbaud
BLKB
$1.65B
| $251K | ﹤0.01% |
3,533
-1,363
| -28% | -$94K |
|
1019
iShares Europe ETF
IEV
$1.64B
| $251K | ﹤0.01% |
5,000
| – | – |
|
1020
abrdn Physical Gold Shares ETF
SGOL
$6.87B
| $250K | ﹤0.01% |
15,250
| – | – |
|
1021
Selective Insurance
SIGI
$5.63B
| $250K | ﹤0.01% |
+3,457
| New | +$241K |
|
|
CLGX
1022
DELISTED
Corelogic, Inc.
CLGX
| $248K | ﹤0.01% |
3,133
-724
| -19% | -$57.7K |
|
1023
Motorola Solutions
MSI
$73.1B
| $247K | ﹤0.01% |
1,317
-30
| -2% | -$5.35K |
|
|
CCXI
1024
DELISTED
ChemoCentryx, Inc.
CCXI
| $246K | ﹤0.01% |
4,806
+59
| +1% | +$3.55K |
|
1025
DXC Technology
DXC
$1.76B
| $245K | ﹤0.01% |
7,866
-9,697
| -55% | -$266K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2021 Portfolio in Review
As of Q1 2021, Glenmede Trust held 1,286 positions worth $18.6B, up 2% from $18.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Glenmede Trust withdrew a net $1.05B in Q1 2021, closing 90 positions and reducing 580 holdings. Its most notable exit was Coherent, an estimated $32.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Glenmede Trust opened a new position in Rollins worth $29.6M.
- Glenmede Trust's largest Q1 2021 buy was Rollins: 860,755 shares worth $29.6M.
- Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $42.1M increase.
- Glenmede Trust's biggest Q1 2021 reduction was Progressive, cutting an estimated $132M.
- Glenmede Trust fully exited Coherent in Q1 2021, selling an estimated $32.9M.
- Glenmede Trust's ten largest holdings make up 20% of its $18.6B portfolio in Q1 2021.
- Glenmede Trust opened 95 new positions and closed 90 in Q1 2021.
- Glenmede Trust's portfolio value rose 2% quarter-over-quarter to $18.6B.
Based on Glenmede Trust's 13F filing for Q1 2021, filed 18 May 2021.